Bergstrom, C. P., Ruffell, B., Ho, C. M., Higano, C. S., Ellis, W. J., Garzotto, M., . . . Graff, J. N. (2017). Docetaxel and Mitoxantrone Prior to Radical Prostatectomy in Men with High Risk Prostate Cancer: Ten-Year Follow Up and Immune Correlates. Anticancer Drugs.
Citação norma ChicagoBergstrom, Colin P., Brian Ruffell, Christine M.T Ho, Celestia S. Higano, William J. Ellis, Mark Garzotto, Tomasz M. Beer, and Julie N. Graff. "Docetaxel and Mitoxantrone Prior to Radical Prostatectomy in Men With High Risk Prostate Cancer: Ten-Year Follow Up and Immune Correlates." Anticancer Drugs 2017.
Citação norma MLABergstrom, Colin P., et al. "Docetaxel and Mitoxantrone Prior to Radical Prostatectomy in Men With High Risk Prostate Cancer: Ten-Year Follow Up and Immune Correlates." Anticancer Drugs 2017.